109 related articles for article (PubMed ID: 3265657)
1. Selective T cell subset depletion with anti-CD4 and anti-CD8 intact ricin immunotoxins.
Izquierdo M; Balboa MA; Figuera A; López-Botet M
Clin Exp Immunol; 1988 Nov; 74(2):300-4. PubMed ID: 3265657
[TBL] [Abstract][Full Text] [Related]
2. Immunotoxin depletion of T cells and its effect on hematopoietic progenitor cells in human cord blood.
Xu M; Lu S; Shen B; Li Y
Chin Med J (Engl); 2001 Apr; 114(4):355-9. PubMed ID: 11780453
[TBL] [Abstract][Full Text] [Related]
3. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
[TBL] [Abstract][Full Text] [Related]
4. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
[TBL] [Abstract][Full Text] [Related]
5. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
Stong RC; Youle RJ; Vallera DA
Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999
[TBL] [Abstract][Full Text] [Related]
6. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
Shen GL; Li JL; Vitetta ES
J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047
[TBL] [Abstract][Full Text] [Related]
7. Cell-type-specific cytotoxicity of anti-CD4 and anti-CD8 ricin immunotoxins against human alloreactive T-cell clones.
Uckun FM; Myers DE; Ledbetter JA; Wee SL; Vallera DA
Blood; 1989 Nov; 74(7):2445-54. PubMed ID: 2572287
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations.
Rigby WF; Yirinec B; Oldershaw RL; Fanger MW
Eur J Immunol; 1987 Apr; 17(4):563-6. PubMed ID: 3106071
[TBL] [Abstract][Full Text] [Related]
9. Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies.
Seon BK
Cancer Res; 1984 Jan; 44(1):259-64. PubMed ID: 6606488
[TBL] [Abstract][Full Text] [Related]
10. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
11. T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease.
Fauser AA; Shustik C; Langleben A; Laurent G; Kanz L; Spurll GM; Price G; Ahlgren PD; Cooper BA
Clin Invest Med; 1988 Feb; 11(1):40-6. PubMed ID: 3284672
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen.
Youle RJ; Uckun FM; Vallera DA; Colombatti M
J Immunol; 1986 Jan; 136(1):93-8. PubMed ID: 3079613
[TBL] [Abstract][Full Text] [Related]
13. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
Ramakrishnan S; Uckun FM; Houston LL
J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
15. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow.
Quinones RR; Youle RJ; Kersey JH; Zanjani ED; Azemove SM; Soderling CC; Lebien TW; Beverley PC; Neville DM; Vallera DA
J Immunol; 1984 Feb; 132(2):678-83. PubMed ID: 6606676
[TBL] [Abstract][Full Text] [Related]
16. Rationale for the selection of ricin A-chain anti-T immunotoxins for mature T cell depletion.
Derocq JM; Laurent G; Casellas P; Vidal H; Poncelet P; Fauser A; Demur C; Jansen F
Transplantation; 1987 Dec; 44(6):763-9. PubMed ID: 3501187
[TBL] [Abstract][Full Text] [Related]
17. Uptake of antibody directed cytotoxic liposomes by CD3 on human T cells.
Gray AG; Morgan J; Linch DC; Huehns ER
Clin Exp Immunol; 1988 Apr; 72(1):168-73. PubMed ID: 3260836
[TBL] [Abstract][Full Text] [Related]
18. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
Uckun FM; Stong RC; Youle RJ; Vallera DA
J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
[TBL] [Abstract][Full Text] [Related]
19. Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicity.
Preijers FW; De Witte T; Rijke-Schilder GP; Tax WJ; Wessels JM; Haanen C; Capel PJ
Scand J Immunol; 1988 Aug; 28(2):185-94. PubMed ID: 3261884
[TBL] [Abstract][Full Text] [Related]
20. High toxic efficiency of ricin immunotoxins specific for the T-cell antigen receptor of a human leukemia T-cell line.
Izquierdo M; Balboa MA; Lamana ML; López-Botet M
Int J Cancer; 1989 Apr; 43(4):697-702. PubMed ID: 2467887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
